Statin and ezetimibe combination

This page covers all Statin and ezetimibe combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting HMG-CoA reductase and NPC1L1 transporter.

Targets

HMG-CoA reductase and NPC1L1 transporter

Marketed (1)

• Rosuvastatin and Ezetimibe · Hanmi Pharmaceutical Company Limited · Cardiovascular
  Rosuvastatin inhibits HMG-CoA reductase to lower LDL cholesterol, while ezetimibe blocks intestinal cholesterol absorption, providing dual lipid-lowering action.